Cholesterol risk management: a systematic examination of the gap from evidence to practice.
Hypercholesterolemia is a major risk factor for coronary heart disease, and data indicate that aggressive cholesterol reduction decreases mortality and morbidity associated with this disease. Many patients with hypercholesterolemia, however, are not screened, prescribed appropriate lipid-lowering therapy, or treated to target cholesterol levels. Practice patterns are particularly inadequate for those patients at highest risk for having a cardiac event. We performed a literature search to identify studies of practice patterns in the management of patients with hypercholesterolemia with regard to screening, implementing lipid-lowering therapy, and treating to lipid goals. The findings highlight the potential for substantial opportunities to improve patient outcomes. Future studies should evaluate reasons for suboptimal cholesterol management as well as provide steps to improve management.
Olson
K L
KL
Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Bungard
T J
TJ
Tsuyuki
R T
RT
D000818:Animals; D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine / Q000379:methods*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000191:economics; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000924:Anticholesteremic Agents